• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

SHS buys minority stake in Blazejewski Medi-Tech

  • Harriet Matthews
  • Harriet Matthews
  • 27 February 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Germany-based healthcare and life sciences investor SHS has bought a minority stake in endoscope manufacturer Blazejewski Medi-Tech.

The GP will own a 24.9% stake, with owner and founder Reinhold Blazejewski retaining a majority stake.

Manfred Ulmer-Weber, senior investment manager at SHS, explained how the deal came about: “We got to know the company around three years ago and we kept in touch after that. From the beginning, we realised that there would be synergies: we liked the company and the potential, and the founder Reinhold Blazejewski knew that we understand medical devices, medical technology and life sciences. Based on the background and the relationship, we met more often, discussed how to cooperate and this turned into the deal.”

Blazejewski Medi-Tech

  • DEAL:

    Buyout

  • LOCATION:

    Sexau

  • SECTOR:

    Medical equipment

  • FOUNDED:

    1991

  • STAFF:

    70

Asked about the strategy for the company, Ulmer-Weber said: “Add-on acquisitions are not the focus: we see strong potential for growth with the company’s client base and the products in 2D and 3D endoscopy systems, as well as robotic systems.”

SHS also plans to assist the company with its international expansion. “We have a clear plan for internationalisation. We are of course looking to strengthen the US business, and we want to look to Asia, too,” said Ulmer-Weber.

SHS deployed equity from SHS IV Fonds, which held a final close in May 2015 on €125m, surpassing its target of €100m. The investment in Blazejewski Meditech marks the last investment from the fund, Ulmer-Weber told Unquote.

The GP will be making future investments from SHS Fonds V, which held a first close in July 2018 on €90m with a target of €150m. The fund has made four investments so far, Ulmer-Weber told Unquote, and has one deal in the pipeline that is expected to close by the end of Q1 2020.

SHS said in a statement that its fifth fund has now received more than €130m in commitments.

Company
Blazejewski Medi-Tech was founded in 1991 by Reinhold Blazejewski. The company employs 70 staff and is based in Sexau, Baden-Wuerttemberg. It produces and distributes 2D and 3D endoscopy equipment for use in operations and medical devices.

People
Gesellschaft für Beteiligungsmanagement
- Manfred Ulmer-Weber (senior investment manager).
Blazejewski Medi-Tech - Reinhold Blazejewski (founder).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • DACH
  • Healthcare
  • Germany

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013